Allometric scaling of pharmacokinetic parameters in drug discovery: can human CL, Vss and t1/2 be predicted from in-vivo rat data?

European Journal of Drug Metabolism and Pharmacokinetics
Gary W CaldwellWilliam Hageman

Abstract

In a drug discovery environment, reasonable go/no-go human in-vivo pharmacokinetic (PK) decisions must be made in a timely manner with a minimum amount of animal in-vivo or in-vitro data. We have investigated the accuracy of the in-vivo correlation between rat and human for the prediction of the total systemic clearance (CL), the volume of distribution at steady state (Vss), and the half-life (t1/2) using simple allometric scaling techniques. We have shown, using a large diverse set of drugs, that a fixed exponent allometric scaling approach can be used to predict human in-vivo PK parameters CL, Vss and t(1/2) solely from rat in-vivo PK data with acceptable accuracy for making go/no-go decisions in drug discovery. Human in-vivo PK predictions can be obtained using the simple allometric scaling relationships CL(Human) approximately = 40 CL(Rat) (L/hr), Vss(Human) approximately = 200 Vss(Rat) (L), and t1/2(Human) approximately = 4 t1/2(Rat) (hr). The average fold error for human CL predictions for N = 176 drugs was 2.25 with 79% of the drugs having a fold error less than 3. The average fold error for human Vss predictions for N = 144 drugs was 1.85 with 84% of the drugs having a fold error less than 3. The average fold error for ...Continue Reading

References

Feb 9, 1990·Journal of Theoretical Biology·C C TravisR C Ward
Feb 1, 1989·Alcoholism, Clinical and Experimental Research·M Galanter, M Bean-Bayog
Apr 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·H Boxenbaum
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·A FanB Davis
Apr 1, 1996·Environmental Health Perspectives·K BachmannD White
Jan 1, 1997·Pharmacology & Therapeutics·T IwatsuboY Sugiyama
Feb 12, 1998·Environmental Health Perspectives·J G SarverK Bachmann
Jan 7, 1999·Life Sciences·I Mahmood
Jun 4, 1999·Journal of Clinical Pharmacology·L IavaroneG C Preston
Nov 17, 1999·Journal of Pharmaceutical Sciences·I Mahmood
Jun 28, 2000·Pharmaceutical Research·M R FengA Hutchaleelaha
Nov 30, 2000·International Journal of Clinical Pharmacology and Therapeutics·W L ChiouH Y Jeong
Dec 21, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·K BeaumontJ Bennett
Aug 22, 2001·Current Drug Metabolism·K A Bachmann, R Ghosh
Sep 8, 2001·Drug Discovery Today·S J.F. Macdonald, P W. Smith
Jan 24, 2002·The Journal of Pharmacy and Pharmacology·J SukbuntherngL Antonian
Mar 20, 2002·Current Topics in Medicinal Chemistry·G W CaldwellZ Yan
Jun 19, 2002·Antimicrobial Agents and Chemotherapy·Mahboubeh Hosseini-Yeganeh, Andrew J McLachlan
Jul 24, 2002·Pharmaceutical Research·Win L Chiou, Paul W Buehler
Oct 31, 2002·Clinical Pharmacokinetics·Dennis SmithBarry Jones
Nov 16, 2002·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yau Yi LauK-C Cheng
Nov 16, 2002·Journal of Pharmaceutical Sciences·Toshihiro WajimaTakayoshi Oguma

❮ Previous
Next ❯

Citations

Jul 14, 2005·European Journal of Drug Metabolism and Pharmacokinetics·Gary W CaldwellWilliam Jones
Sep 16, 2011·Nucleic Acid Therapeutics·Iftekhar Mahmood
Feb 4, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hongliang CaiJeffrey C Stevens
Aug 21, 2013·Biochemical Pharmacology·Paul McGonigle, Bruce Ruggeri
May 18, 2012·Expert Opinion on Drug Metabolism & Toxicology·Peng ZouDuxin Sun
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Keith W Ward
Jul 25, 2006·Expert Opinion on Drug Metabolism & Toxicology·David E Leahy
Jul 1, 2008·Expert Opinion on Drug Discovery·Simon Thomas
Jan 8, 2016·Science Translational Medicine·Melodi Javid WhitleyBrian E Brigman
Jan 8, 2008·Journal of Veterinary Pharmacology and Therapeutics·L K Maxwell, E R Jacobson
Mar 16, 2016·Chemical Research in Toxicology·Svava Ósk JónsdóttirElsa Nielsen
Jun 15, 2016·BMC Complementary and Alternative Medicine·Lieselotte VeryserBart De Spiegeleer
Jul 6, 2014·Medical Hypotheses·Oscar A LinaresRaymond C Boston
Feb 22, 2017·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Yoo-Seong JeongSuk-Jae Chung
Mar 8, 2017·Integrative Biology : Quantitative Biosciences From Nano to Macro·Christian MaassMurat Cirit
Nov 11, 2017·BMC Biology·Shinichi NakagawaMalgorzata Lagisz
Nov 22, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Barbra Sanches MoraesSandra Elisa Haas
Jun 16, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·I Mahmood
Aug 10, 2010·Clinical Pharmacokinetics·Zvi TeitelbaumAdam F Cohen
Dec 30, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yongjun Hu, David E Smith
May 23, 2019·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Philip GardinerKen Grime
Aug 18, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Franco LombardoR Scott Obach
Apr 23, 2008·Drug Metabolism and Disposition : the Biological Fate of Chemicals·R Scott ObachNigel J Waters
Sep 26, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Li DiR Scott Obach
Jul 23, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Philip Gardiner, Stuart W Paine
Jul 17, 2019·Journal of Translational Medicine·Cathalijn H C LeenaarsFranck L B Meijboom
Jun 20, 2019·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Carl PeterssonHugues Dolgos
Jul 20, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Aug 14, 2020·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Michael J EspirituJohn P Harrelson
Oct 14, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·F A BrightmanS Thomas
Apr 20, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Christopher A EvansKeith W Ward
Oct 20, 2009·Journal of Clinical Pharmacology·Jie LingHugh M Davis
Sep 22, 2007·The Journal of Pharmacy and Pharmacology·Urban Fagerholm
Oct 20, 2018·Naunyn-Schmiedeberg's Archives of Pharmacology·Max Kenedy Felix Dos SantosBruno Lobão-Soares

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.